Evie Koslosky
Stock Analyst at Goldman Sachs
(3.97)
# 1,796
Out of 5,078 analysts
56
Total ratings
78.1%
Success rate
14.8%
Average return
Main Sectors:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintained: Buy | $685 → $830 | $694.02 | +19.59% | 2 | Oct 22, 2026 | |
| DHR Danaher | Maintained: Buy | $250 → $275 | $233.86 | +17.59% | 7 | Oct 22, 2026 | |
| BRKR Bruker | Reiterated: Sell | $50 | $59.11 | -15.40% | 6 | Oct 5, 2026 | |
| GRAL GRAIL | Reiterated: Hold | $75 → $120 | $132.60 | -9.50% | 4 | Oct 5, 2026 | |
| ADPT Adaptive Biotechnologies | Initiated Coverage: Buy | $35 | $25.33 | +38.18% | 1 | Sep 29, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | $75 | $67.76 | +10.68% | 1 | Sep 22, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $175 → $185 | $177.75 | +4.08% | 5 | Sep 20, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $27 → $35 | $32.35 | +8.19% | 3 | Sep 20, 2026 | |
| GH Guardant Health | Reiterated: Buy | $210 → $225 | $166.66 | +35.01% | 8 | Sep 20, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Hold | $1,340 → $1,510 | $1,677.94 | -10.01% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $270 → $375 | $413.38 | -9.28% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 → $140 | $156.61 | -10.61% | 3 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $17.77 | +35.06% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 → $515 | $457.47 | +12.58% | 4 | Sep 20, 2026 |
Thermo Fisher Scientific
Oct 22, 2026
Maintained: Buy
Price Target: $685 → $830
Current: $694.02
Upside: +19.59%
Danaher
Oct 22, 2026
Maintained: Buy
Price Target: $250 → $275
Current: $233.86
Upside: +17.59%
Bruker
Oct 5, 2026
Reiterated: Sell
Price Target: $50
Current: $59.11
Upside: -15.40%
GRAIL
Oct 5, 2026
Reiterated: Hold
Price Target: $75 → $120
Current: $132.60
Upside: -9.50%
Adaptive Biotechnologies
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $25.33
Upside: +38.18%
Tempus AI
Sep 22, 2026
Initiated Coverage: Hold
Price Target: $75
Current: $67.76
Upside: +10.68%
Agilent Technologies
Sep 20, 2026
Reiterated: Buy
Price Target: $175 → $185
Current: $177.75
Upside: +4.08%
Caris Life Sciences
Sep 20, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $32.35
Upside: +8.19%
Guardant Health
Sep 20, 2026
Reiterated: Buy
Price Target: $210 → $225
Current: $166.66
Upside: +35.01%
Mettler-Toledo International
Sep 20, 2026
Reiterated: Hold
Price Target: $1,340 → $1,510
Current: $1,677.94
Upside: -10.01%
Sep 20, 2026
Reiterated: Hold
Price Target: $270 → $375
Current: $413.38
Upside: -9.28%
Sep 20, 2026
Reiterated: Hold
Price Target: $100 → $140
Current: $156.61
Upside: -10.61%
Sep 20, 2026
Reiterated: Buy
Price Target: $24
Current: $17.77
Upside: +35.06%
Sep 20, 2026
Rated: Buy
Price Target: $425 → $515
Current: $457.47
Upside: +12.58%